Clinical implications of the Women's Ischemia Syndrome Evaluation: Inter-relationships between symptoms, psychosocial factors and cardiovascular outcomes

Women's Health

Volumn 9, Issue 5, 2013, Pages 479-490

  Handberg, Eileen M ^a   Eastwood, Jo Ann ^b   Eteiba, Wafia ^c   Johnson, B Delia ^c   Krantz, David S ^d   Thompson, Diane V ^e   Vaccarino, Viola ^f   Bittner, Vera ^g   Sopko, George ^h   Pepine, Carl J ^a   Merz, Noel Bairey ⁱ   Rutledge, Thomas R ^j,k  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d Uniformed Services University of the Health Sciences   (United States)

^e ALLEGHENY GENERAL HOSPITAL   (United States)

^f EMORY UNIVERSITY   (United States)

^g University of Alabama at Birmingham   (United States)

^h NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

ⁱ CEDARS SINAI MEDICAL CENTER   (United States)

^j VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^k UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

anxiety; chest pain; coronary artery disease; depression; nonobstructive disease; women

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT;

ANGINA PECTORIS; ANXIETY; BECK DEPRESSION INVENTORY; CARDIAC ANXIETY; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; COHORT ANALYSIS; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; FALSE NEGATIVE RESULT; FEMALE; FOLLOW UP; FUNCTIONAL STATUS; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEART MUSCLE ISCHEMIA; HOSTILITY; HUMAN; LOWEST INCOME GROUP; MEDICAL HISTORY; MORBIDITY; PERSISTENT THORAX PAIN; PREDICTIVE VALUE; PSYCHOLOGIC ASSESSMENT; QUALITY OF LIFE; REVIEW; SENSITIVITY AND SPECIFICITY; SOCIAL NETWORK; SOCIAL PSYCHOLOGY; STATE TRAIT ANXIETY INVENTORY; SYMPTOM; THORAX PAIN; WOMEN'S HEALTH;

AGED; ANXIETY; CARDIOVASCULAR DISEASES; CHEST PAIN; COMORBIDITY; CORONARY ARTERY DISEASE; COSTS AND COST ANALYSIS; DEPRESSION; HEALTH SERVICES; HUMANS; MENTAL HEALTH; MIDDLE AGED; MYOCARDIAL ISCHEMIA; QUALITY OF LIFE; RISK; SOCIOECONOMIC FACTORS; SYNDROME; WOMEN'S HEALTH;

EID: 84883620372     PISSN: 17455057     EISSN: 17455065     Source Type: Journal    
DOI: 10.2217/whe.13.50     Document Type: Review

References (73)

1. Go AS, Mozaffarian D, Roger VL et al. Executive summary: heart disease and stroke statistics - 2013 update: A report from the American Heart Association. Circulation 127(1), 143-152 (2013).
2. Everson-Rose SA, Lewis TT. Psychosocial factors and cardiovascular diseases. Ann. Rev. Public Health 26, 469-500 (2005). (Pubitemid 40547393)
3. Krantz DS, McCeney MK. Effects of psychological and social factors on organic disease: A critical assessment of research on coronary heart disease. Ann. Rev. Psychol. 53, 341-369 (2002).
4. Low CA, Thurston RC, Matthews KA. Psychosocial factors in the development of heart disease in women: current research and future directions. Psychosom. Med. 72(9), 842-854 (2010).
5. Merz CN, Kelsey SF, Pepine CJ et al. The Women's Ischemia Syndrome Evaluation (WISE) study: protocol design, methodology and feasibility report. J. Am. Coll. Cardiol. 33(6), 1453-1461 (1999).
6. Barefoot JC, Dodge KA, Peterson BL, Dahlstrom WG, Williams RB Jr. The Cook-Medley hostility scale: item content and ability to predict survival. Psychosom. Med. 51(1), 46-57 (1989). (Pubitemid 19056762)
7. Cook WW, Medley DM. Proposed hostility and pharisaic-virtue scales for the MMPI. J. Applied Psychol. 38, 414-418 (1954).
8. Beck AT. Depression Inventory. Center for Cognitive Therapy, PA, USA (1978).
9. Spielberger CD, Gorsuch RC, Lushene RE. Manual for the State Trait Anxiety Inventory. Consulting Psychologists Press, CA, USA (1970).
10. Spielberger CD, Johnson EH, Russell SF, Crane RJ, Jacobs GA, Worden TJ. The experience and expression of anger: construction and validation of an anger expression scale. In: Anger and Hostility in Cardiovascular and Behavioral Disorders. Chesney MA, Rosenman RH (Eds). Hemisphere/McGraw-Hill, NY, USA, 5-30 (1985).
11. Schmidt NB, Telch MJ. Role of fear and safety information in moderating the effects of voluntary hyperventilation. Behav. Ther. 25(2), 197-208 (1994). (Pubitemid 24187560)
12. Cohen S, Mermelstein R, Lkamarck T, Hoberman H. Measuring the functional components of social support. In: Social Support: Theory, Research, and Applications. Sarason IG, Sarason BR (Eds). Springer- Verlag, NY, USA, 73-94 (1985).
13. Wu AW, Hays RD, Kelly S, Malitz F, Bozzette SA. Applications of the medical outcomes study health-related quality of life measures in HIV/AIDS. Qual. Life Res. 6(6), 531-554 (1997). (Pubitemid 27431708)
14. Diamond GA, Staniloff HM, Forrester JS, Pollock BH, Swan HJ. Computer-assisted diagnosis in the noninvasive evaluation of patients with suspected coronary artery disease. J. Am. Coll. Cardiol. 1(2 Pt 1), 444-455 (1983). (Pubitemid 13063197)
15. Olson MB, Kelsey SF, Matthews K et al. Symptoms, myocardial ischaemia and quality of life in women: results from the NHLBI-sponsored WISE Study. Eur. Heart J. 24(16), 1506-1514 (2003). (Pubitemid 37010581)
16. Johnson BD, Kelsey SF, Bairey Merz CN. Clinical risk assessment in women: chest discomfort. Report from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) Study. In: Contemporary Cardiology: Coronary Disease in Women: Evidence-Based Diagnosis and Treatment. Shaw L, Hachamovitch R, Redberg R, Culler S (Eds). Humana Press, NJ, USA, 129-141 (2003).
17. Vaccarino V, Parsons L, Every NR, Barron HV, Krumholz HM. Sex-based differences in early mortality after myocardial infarction. National Registry of Myocardial Infarction 2 Participants. N. Engl. J. Med. 341(4), 217-225 (1999). (Pubitemid 29334519)
18. Eastwood JA, Johnson BD, Rutledge T et al. Anginal symptoms, coronary artery disease, and adverse outcomes in black and white women: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) study. J. Womens Health (2013) (In Press).
19. Johnson BD, Shaw LJ, Pepine CJ et al. Persistent chest pain predicts cardiovascular events in women without obstructive coronary artery disease: results from the NIH-NHLBI-sponsored Women's Ischaemia Syndrome Evaluation (WISE) study. Eur. Heart J. 27(12), 1408-1415 (2006).
20. Olafiranye O, Jean-Louis G, Zizi F, Nunes J, Vincent M. Anxiety and cardiovascular risk: review of epidemiological and clinical evidence. Mind Brain 2(1), 32-37 (2011).
21. Pajak A, Jankowski P, Kotseva K, Heidrich J, de Smedt D, de Bacquer D. Depression, anxiety, and risk factor control in patients after hospitalization for coronary heart disease: the EUROASPIRE III Study. Eur. J. Prev. Cardiol. 20(2), 331-340 (2013).
22. Moser DK, McKinley S, Riegel B et al. Relationship of persistent symptoms of anxiety to morbidity and mortality outcomes in patients with coronary heart disease. Psychosom. Med. 73(9), 803-809 (2011).
23. Roest AM, Martens EJ, de Jonge P, Denollet J. Anxiety and risk of incident coronary heart disease: A meta-analysis. J. Am. Coll. Cardiol. 56(1), 38-46 (2010).
24. Gater R, Tansella M, Korten A, Tiemens BG, Mavreas VG, Olatawura MO. Sex differences in the prevalence and detection of depressive and anxiety disorders in general health care settings: report from the World Health Organization Collaborative Study on Psychological Problems in General Health Care. Arch. Gen. Psychiatry 55(5), 405-413 (1998). (Pubitemid 28237273)
25. Chiaramonte GR, Friend R. Medical students' and residents' gender bias in the diagnosis, treatment, and interpretation of coronary heart disease symptoms. Health Psychol. 25(3), 255-266 (2006). (Pubitemid 44128254)
26. Steingart RM, Packer M, Hamm P et al. Sex differences in the management of coronary artery disease. Survival and Ventricular Enlargement Investigators. N. Engl. J. Med. 325(4), 226-230 (1991).
27. Bosner S, Haasenritter J, Hani MA et al. Gender bias revisited: new insights on the differential management of chest pain. BMC Fam. Pract. 12, 45 (2011).
28. Krantz DS, Whittaker KS, Francis JL et al. Psychotropic medication use and risk of adverse cardiovascular events in women with suspected coronary artery disease: outcomes from the Women's Ischemia Syndrome Evaluation (WISE) study. Heart 95(23), 1901-1906 (2009).
29. Rutledge T, Kenkre TS, Bittner V et al. Anxiety associations with cardiac symptoms, angiographic disease severity, and healthcare utilization: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation. Int. J. Cardiol. doi:10.1016/j.ijcard.1001.1036 (2013) (Epub ahead of print).
30. Rutledge T, Linke SE, Krantz DS et al. Comorbid depression and anxiety symptoms as predictors of cardiovascular events: results from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) study. Psychosom. Med. 71(9), 958-964 (2009).
31. Rutledge T, Reis SE, Olson M et al. History of anxiety disorders is associated with a decreased likelihood of angiographic coronary artery disease in women with chest pain: the WISE study. J. Am. Coll. Cardiol. 37(3), 780-785 (2001). (Pubitemid 32202445)
32. Whittaker KS, Krantz DS, Rutledge T et al. Combining psychosocial data to improve prediction of cardiovascular disease risk factors and events: the National Heart, Lung, and Blood Institute - sponsored Women's Ischemia Syndrome Evaluation study. Psychosom. Med. 74(3), 263-270 (2012).
33. Smoller JW, Pollack MH, Wassertheil-Smoller S et al. Panic attacks and risk of incident cardiovascular events among postmenopausal women in the Women's Health Initiative Observational Study. Arch. Gen. Psychiatry 64(10), 1153-1160 (2007). (Pubitemid 47529339)
34. Watkins LL, Blumenthal JA, Babyak MA et al. Phobic anxiety and increased risk of mortality in coronary heart disease. Psychosom. Med. 72(7), 664-671 (2010).
35. Roest AM, Martens EJ, Denollet J, de Jonge P. Prognostic association of anxiety post myocardial infarction with mortality and new cardiac events: A meta-analysis. Psychosom. Med. 72(6), 563-569 (2010).
36. Albert CM, Chae CU, Rexrode KM, Manson JE, Kawachi I. Phobic anxiety and risk of coronary heart disease and sudden cardiac death among women. Circulation 111(4), 480-487 (2005). (Pubitemid 40204433)
37. Rutledge T, Reis SE, Olson M et al. Psychosocial variables are associated with atherosclerosis risk factors among women with chest pain: the WISE study. Psychosom. Med. 63(2), 282-288 (2001). (Pubitemid 32249953)
38. Linke SE, Rutledge T, Johnson BD et al. Depressive symptom dimensions and cardiovascular prognosis among women with suspected myocardial ischemia: A report from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation. Arch. Gen. Psychiatry 66(5), 499-507 (2009).
39. Rutledge T, Linke SE, Johnson BD et al. Relationships between cardiovascular disease risk factors and depressive symptoms as predictors of cardiovascular disease events in women. J. Womens Health (Larchmt) 21(2), 133-139 (2012).
40. Rutledge T, Reis SE, Olson M et al. Depression is associated with cardiac symptoms, mortality risk, and hospitalization among women with suspected coronary disease: the NHLBI-sponsored WISE study. Psychosom. Med. 68(2), 217-223 (2006). (Pubitemid 43740124)
41. Rutledge T, Reis SE, Olson MB et al. Depression symptom severity and reported treatment history in the prediction of cardiac risk in women with suspected myocardial ischemia: the NHLBI-sponsored WISE study. Arch. Gen. Psychiatry 63(8), 874-880 (2006). (Pubitemid 44188480)
42. Rutledge T, Vaccarino V, Johnson BD et al. Depression and cardiovascular health care costs among women with suspected myocardial ischemia: prospective results from the WISE (Women's Ischemia Syndrome Evaluation) Study. J. Am. Coll. Cardiol. 53(2), 176-183 (2009).
43. Vaccarino V, Johnson BD, Sheps DS et al. Depression, inflammation, and incident cardiovascular disease in women with suspected coronary ischemia: the National Heart, Lung, and Blood Institute-sponsored WISE study. J. Am. Coll. Cardiol. 50(21), 2044-2050 (2007). (Pubitemid 350087570)
44. Vaccarino V, Mcclure C, Johnson BD et al. Depression, the metabolic syndrome and cardiovascular risk. Psychosom. Med. 70(1), 40-48 (2008).
45. Mallik S, Spertus JA, Reid KJ et al. Depressive symptoms after acute myocardial infarction: evidence for highest rates in younger women. Arch. Intern. Med. 166(8), 876-883 (2006).
46. Hoen PW, Whooley MA, Martens EJ, Na B, van Melle JP, de Jonge P. Differential associations between specific depressive symptoms and cardiovascular prognosis in patients with stable coronary heart disease. J. Am. Coll. Cardiol. 56(11), 838-844 (2010).
47. Brorsson B, Bernstein SJ, Brook RH, Werko L. Quality of life of patients with chronic stable angina before and four years after coronary revascularisation compared with a normal population. Heart 87(2), 140-145 (2002). (Pubitemid 34098376)
48. Gravely-Witte S, de Gucht V, Heiser W, Grace SL, Van Elderen T. The impact of angina and cardiac history on health-related quality of life and depression in coronary heart disease patients. Chronic Illn. 3(1), 66-76 (2007). (Pubitemid 47434425)
49. Hlatky MA, Boineau RE, Higginbotham MB et al. A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index). Am. J. Cardiol. 64(10), 651-654 (1989). (Pubitemid 19230238)
50. Timmis AD, Feder G, Hemingway H. Prognosis of stable angina pectoris: why we need larger population studies with higher endpoint resolution. Heart 93(7), 786-791 (2007). (Pubitemid 46998975)
51. Shaw LJ, Merz CN, Bittner V et al. Importance of socioeconomic status as a predictor of cardiovascular outcome and costs of care in women with suspected myocardial ischemia. Results from the National Institutes of Health, National Heart, Lung and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE). J. Womens Health (Larchmt) 17(7), 1081-1092 (2008).
52. Shaw LJ, Olson MB, Kip K et al. The value of estimated functional capacity in estimating outcome: results from the NHBLI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study. J. Am. Coll. Cardiol. 47(Suppl. 3), S36-S43 (2006).
53. Lecrubier Y. The burden of depression and anxiety in general medicine. J. Clin. Psychiatry 62(Suppl. 8), 4-9; discussion 10-11 (2001).
54. Luppa M, Heinrich S, Angermeyer MC, Konig HH, Riedel-Heller SG. Cost-of-illness studies of depression: A systematic review. J. Affect. Disord. 98(1-2), 29-43 (2007). (Pubitemid 46048916)
55. Simon GE, Katon WJ, Lin EH et al. Cost-effectiveness of systematic depression treatment among people with diabetes mellitus. Arch. Gen. Psychiatry 64(1), 65-72 (2007). (Pubitemid 46041740)
56. Sullivan M, Simon G, Spertus J, Russo J. Depression-related costs in heart failure care. Arch. Intern. Med. 162(16), 1860-1866 (2002).
57. Henk HJ, Katzelnick DJ, Kobak KA, Greist JH, Jefferson JW. Medical costs attributed to depression among patients with a history of high medical expenses in a health maintenance organization. Arch. Gen. Psychiatry 53(10), 899-904 (1996). (Pubitemid 26357176)
58. Simon GE, Vonkorff M, Barlow W. Health care costs of primary care patients with recognized depression. Arch. Gen. Psychiatry 52(10), 850-856 (1995).
59. Barth J, Schumacher M, Herrmann-Lingen C. Depression as a risk factor for mortality in patients with coronary heart disease: A meta-analysis. Psychosom. Med. 66(6), 802-813 (2004). (Pubitemid 39552862)
60. Musselman DL, Evans DL, Nemeroff CB. The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch. Gen. Psychiatry 55(7), 580-592 (1998). (Pubitemid 28340345)
61. Gulati M, Cooper-Dehoff RM, McClure C et al. Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: A report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project. Arch. Intern. Med. 169(9), 843-850 (2009).
62. Jespersen L, Hvelplund A, Abildstrom SZ et al. Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. Eur. Heart J. 33(6), 734-744 (2012).
63. Gibbons RJ, Abrams J, Chatterjee K et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina - summary article: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). Circulation 107(1), 149-158 (2003). (Pubitemid 36070948)
64. Cuijpers P, Smit F, Oostenbrink J, de Graaf R, Ten Have M, Beekman A. Economic costs of minor depression: A population-based study. Acta Psychiatr. Scand. 115(3), 229-236 (2007).
65. Cuijpers P, de Graaf R, van Dorsselaer S. Minor depression: risk profiles, functional disability, health care use and risk of developing major depression. J. Affect. Disord. 79(1-3), 71-79 (2004). (Pubitemid 38340531)
66. Wagner HR, Burns BJ, Broadhead WE, Yarnall KS, Sigmon A, Gaynes BN. Minor depression in family practice: functional morbidity, co-morbidity, service utilization and outcomes. Psychol. Med. 30(6), 1377-1390 (2000).
67. Vasiliadis HM, Dionne PA, Preville M, Gentil L, Berbiche D, Latimer E. The excess healthcare costs associated with depression and anxiety in elderly living in the community. Am. J. Geriatr. Psychiatry 21(6), 536-48 (2012).
68. Shaw LJ, Merz CN, Pepine CJ et al. The economic burden of angina in women with suspected ischemic heart disease: results from the National Institutes of Health - National Heart, Lung, and Blood Institute - sponsored Women's Ischemia Syndrome Evaluation. Circulation 114(9), 894-904 (2006). (Pubitemid 44337132)
69. Asbury EA, Creed F, Collins P. Distinct psychosocial differences between women with coronary heart disease and cardiac syndrome X. Eur. Heart J. 25(19), 1695-1701 (2004). (Pubitemid 39286634)
70. Valeriani M, Sestito A, Le Pera D et al. Abnormal cortical pain processing in patients with cardiac syndrome X. Eur. Heart J. 26(10), 975-982 (2005). (Pubitemid 40695028)
71. Rutledge T, Reis SE, Olson M et al. Socioeconomic status variables predict cardiovascular disease risk factors and prospective mortality risk among women with chest pain. The WISE Study. Behav. Modif. 27(1), 54-67 (2003).
72. Adler NE, Newman K. Socioeconomic disparities in health: pathways and policies. Health Aff. (Millwood). 21(2), 60-76 (2002).
73. Marmot M, Shipley M, Brunner E, Hemingway H. Relative contribution of early life and adult socioeconomic factors to adult morbidity in the Whitehall II study. J. Epidemiol. Community Health 55(5), 301-307 (2001). (Pubitemid 32336968)